WAIKOLOA, Hawaii — A study found that patients were less comfortable when receiving povidone-iodine as ocular antisepsis before an intravitreal injection compared with aqueous chlorhexidine, a speaker reported at Retina 2022.
Sunir J. Garg, MD, FACS, co-director of retina research at Wills Eye Hospital, presented results of a prospective, double-armed interventional study that compared povidone-iodine 5% with aqueous chlorhexidine 0.1% in 100 eyes of 50 patients undergoing same-day bilateral intravitreal injections. One eye of each patient received povidone-iodine while the other eye